Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Palisade Bio, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 23 | +23 |
| Shares | 0 | 2.49M | +2.49M |
| Value | $0 | $10.1M | +$10.1M |
New holders (23)
Institutions that held Palisade Bio, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Altium Capital Management LP | 1,824,894 | $7.43M | 1.72% |
| Vanguard Group Inc | 237,811 | $968.0K | 0.00% |
| Renaissance Technologies LLC | 145,300 | $591.0K | 0.00% |
| Strategic Wealth Designers | 53,129 | $216.0K | 0.08% |
| Sabby Management, LLC | 52,500 | $214.0K | 0.05% |
| State Street Corp | 28,210 | $115.0K | 0.00% |
| BlackRock Inc. | 24,707 | $101.0K | 0.00% |
| Geode Capital Management, LLC | 24,675 | $100.0K | 0.00% |
| UBS Group AG | 22,138 | $90.0K | 0.00% |
| Private Advisor Group, LLC | 21,051 | $86.0K | 0.00% |
| Virtu Financial LLC | 18,200 | $74.0K | 0.01% |
| HighTower Advisors, LLC | 16,666 | $68.0K | 0.00% |
| Citadel Advisors LLC | 10,425 | $42.0K | 0.00% |
| Morgan Stanley | 3,935 | $16.0K | 0.00% |
| Evermay Wealth Management LLC | 1,666 | $7.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 909 | $4.00K | 0.00% |
| Wells Fargo & Company | 240 | $1.00K | 0.00% |
| Bank of America Corp | 3 | $0 | 0.00% |
| Advisor Group Holdings, Inc. | 86 | $0 | 0.00% |
| Sterling Investment Advisors, Ltd. | 5 | $0 | 0.00% |
| Centerpoint Advisors, LLC | 9 | $0 | 0.00% |
| Lindbrook Capital, LLC | 9 | $0 | 0.00% |
| Aspire Private Capital, LLC | 34 | $0 | 0.00% |
Sold out (0)
Institutions that held Palisade Bio, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.